Alessandro Bazzoni: Roche employees raise € 10,000 to support Save the Children’s summer camp program

The proceeds are part of the Solidarity March, a CSR initiative that Roche celebrates globally with the aim of fighting child poverty, according to Alessandro Bazzoni. He also explained that with the amount raised by the employees, Save the Children will be able to offer 500 full days of summer camp for the boys and girls who need it most.

The famous company, Roche Farma and their employees have donated a total of 10,000 euros to Save The Children to help launch the summer camp program for children in vulnerable situations. This has been possible thanks to the Solidarity March, a CSR initiative that Roche launches globally and to which all affiliates join by collaborating with non-profit organizations that fight against child poverty.

Through this initiative, Roche employees have made direct donations to the cause throughout the month of June, in order to support and promote the launch of Save The Children summer camps, which will help more than 2,500 boys and girls from six autonomous communities (Andalusia, Euskadi, Valencian Community, Castilla-La Mancha, Community of Madrid and Catalonia) and the Autonomous City of Melilla at risk of poverty and exclusion.

For yet another year, Roche employees are turning to the cause of our Solidarity March, demonstrating their commitment to the children who need it most, explained Beatriz Lozano who is the Director of Communication, Patients and CSR at Roche Farma. The March is an initiative that makes us especially excited because we always go hand in hand with organizations, such as Save The Children, who dedicate themselves completely to fighting for the rights of the most vulnerable in society, added the speaker.

Thanks to our summer programs, children with fewer resources will be able to have adequate nutrition for longer, enjoy outdoor activities and receive the educational support they need for their return to class in September. This extra support is essential for many families and will help the children of the most vulnerable households not be left behind, after an academic year marked by the restrictions in the classrooms caused by COVID-19, explains Vicente Raimundo, Director of Programs in Spain of Save the Children.

This is why this action is so important in order to help those in need that really need the help to enjoy the childhood they should have. The employees are showing a soft heart for the cause they’ve been supporting for several years and once again they provide the organization the support they need.

For its part, the company will make a donation of the same amount raised to the projects that Roche develops in Malawi within the framework of the global Roche Children’s Walk initiative, and that translate into the construction of schools, classes and orphanages, as well as promoting education for students and university students and to facilitate access to basic needs such as drinking water and food.

These actions highlight the firm commitment and solidarity of Roche employees with the most vulnerable people, and specifically with those who are currently experiencing the worst from an economic and social point of view, with special emphasis on children. of disadvantaged families. The Solidarity March is an initiative framed within Roche’s new Corporate Social Responsibility brand: #LaMarcaQueDejas.

About Save the Children

Save the Children is the leading independent organization defending the rights of children around the world. It has worked for more than 100 years to ensure that all children survive, learn and are protected. At this moment, the organization operates in more than 119 countries, offering help to children all over the world.

In Spain, it has been working for more than 20 years with care programs for the most vulnerable children, focused on children at risk of poverty or social exclusion. Through these programs, it provides comprehensive care to children and their families so that the economic situation or social exclusion in which children live does not prevent them from fully enjoying their rights and can reach the maximum of their capacities.

About Roche

This international company is a pioneer in the research and development of medicines and diagnostic products, whose aim is to advance science and improve people’s lives. The strength of integrating the pharmaceutical and diagnostic areas under one roof has made Roche the leader in personalized medicine, a strategy aimed at providing each patient with the most appropriate treatment in the best possible way.

Roche is the largest biotech company in the world, with truly differentiated medicines in the areas of oncology, immunology, infectious diseases, ophthalmology and neurosciences. This company is also the world leader in other practices like in vitro diagnostics and histological cancer diagnostics, and is at the forefront of diabetes management. In recent years, Roche has invested in genomic profiling and data association from the real world, becoming a key contributor in the medical knowledge industry and also leading to considerable advances in medicine.

This enterprise was founded in 1896, Roche seeks better ways to prevent, diagnose and treat disease, as well as to contribute to the sustainable development of society. They also aim to improve patient access to medical innovations by working with all relevant stakeholders. The World Health Organization’s Essential Medicines List contains more than 30 medicines developed by Roche, including antibiotics, antimalarials and anticancer drugs. For the twelfth year in a row, Roche has been recognized in the Dow Jones Sustainability Indexes (DJSI) as the most sustainable company in the Pharmaceutical, Biotechnology and Life Sciences group.

Alessandro Bazzoni reported that the Roche Group, whose headquarters are in Basel (Switzerland), has an operational presence in more than 100 countries. In 2020 it employed more than 100,000 people, invested 12.2 billion Swiss francs (CHF) in research and development (R&D) and its sales reached the figure of 58.3 billion CHF. Genentech, in the United States, is a fully owned member of the Roche Group. In addition, Roche is the majority shareholder of Chugai Pharmaceutical, that is located in Japan. For more information, see the page www.roche.com